Canova N - Search Results

1

A phase II study on lonidamine combined with cisplatin and etoposide in the treatment of advanced non-small cell bronchogenic carcinoma (NSCBC).

Lelli G, Guaraldi M, Canova N, Casadio M, Pannuti F. Lelli G, et al. Among authors: canova n. J Chemother. 1990 Dec;2(6):401-4. doi: 10.1080/1120009x.1990.11739053. J Chemother. 1990. PMID: 1965508

2

Cisplatinum plus epirubicin alternated with cyclophosphamide plus 5-fluorouracil in ovarian cancer.

Martoni A, Ercolino L, Bellucco A, Canova N, Lelli G, Pannuti F. Martoni A, et al. Among authors: canova n. J Chemother. 1990 Feb;2(1):62-6. doi: 10.1080/1120009x.1990.11738983. J Chemother. 1990. PMID: 2332785

3

High-dose medroxyprogesterone acetate versus oophorectomy as first-line therapy of advanced breast cancer in premenopausal patients.

Martoni A, Longhi A, Canova N, Pannuti F. Martoni A, et al. Among authors: canova n. Oncology. 1991;48(1):1-6. doi: 10.1159/000226884. Oncology. 1991. PMID: 1824798 Clinical Trial.

4

Four-year analysis of platinum and anthracycline combination for ovarian cancer.

Martoni A, Bellucco A, Canova N, Pannuti F. Martoni A, et al. Among authors: canova n. Oncology. 1989;46(2):109-16. doi: 10.1159/000226696. Oncology. 1989. PMID: 2710475

5

4'-Epidoxorubicin plus cisplatin as first-line therapy in the treatment of small cell bronchogenic carcinoma.

Lelli G, Casadio M, Giordani S, Giuliotti C, Canova N, Martoni A, Pannuti F. Lelli G, et al. Among authors: canova n. Chemioterapia. 1987 Apr;6(2):134-6. Chemioterapia. 1987. PMID: 3036379

6

Mitoxantrone, 5-fluorouracil and cyclophosphamide in advanced breast cancer.

Martoni A, Rani P, Ercolino L, Canova N, Pannuti F. Martoni A, et al. Among authors: canova n. Chemioterapia. 1988 Oct;7(5):345-9. Chemioterapia. 1988. PMID: 3224403

7

CA 15.3 and CEA plasma level monitoring in patients with breast cancer.

Martoni A, Ercolino L, Bellanova B, Zanichelli L, Canova N, Pannuti F. Martoni A, et al. Among authors: canova n. Int J Biol Markers. 1988 Jul-Sep;3(3):154-8. doi: 10.1177/172460088800300302. Int J Biol Markers. 1988. PMID: 3230334

8

Medroxyprogesterone acetate (MAP) and tamoxifen (TMX) plasma levels after simultaneous treatment with 'low' TMX and 'high' MAP doses.

Camaggi CM, Strocchi E, Canova N, Costanti B, Pannuti F. Camaggi CM, et al. Among authors: canova n. Cancer Chemother Pharmacol. 1985;14(3):229-31. doi: 10.1007/BF00258121. Cancer Chemother Pharmacol. 1985. PMID: 3158448

9

Medroxyprogesterone acetate (MAP) plasma levels after simultaneous oral and intramuscular administration in cancer patients.

Pannuti F, Camaggi CM, Strocchi E, Giovannini M, Canova N, Murari G. Pannuti F, et al. Among authors: canova n. Cancer Chemother Pharmacol. 1982;9(2):122-3. doi: 10.1007/BF00265393. Cancer Chemother Pharmacol. 1982. PMID: 6216987

10

High-performance liquid chromatographic analysis of tamoxifen and major metabolites in human plasma.

Camaggi CM, Strocchi E, Canova N, Pannuti F. Camaggi CM, et al. Among authors: canova n. J Chromatogr. 1983 Jul 8;275(2):436-42. doi: 10.1016/s0378-4347(00)84393-5. J Chromatogr. 1983. PMID: 6619251 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters